| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 217.397.102 $ | +46.716.869 $ | +20,3 % | 22 | 215.370.002 $ | +44.878.179 $ | +24,1 % | 24 | 170.491.823 $ | +170.491.823 $ | 23 | |||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 31.871.032 $ | +9.602.956 $ | +43,1 % | 1 | 22.268.076 $ | +22.268.076 $ | 1 | ||||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 26.885.839 $ | +2.683.996 $ | +11,1 % | 1 | 24.201.843 $ | +4.146.920 $ | +20,7 % | 1 | 20.054.923 $ | +20.054.923 $ | 1 | |
| Shattuck Labs, Inc. | STTK | → 0 | Neutral | 25.867.795 $ | +5.613.893 $ | +27,7 % | 1 | 20.253.902 $ | +8.756.741 $ | +76,2 % | 1 | 11.497.161 $ | +11.497.161 $ | 1 | |
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 25.126.990 $ | +13.948.609 $ | +124,8 % | 1 | 11.178.381 $ | +5.985.227 $ | +115,3 % | 1 | 5.193.154 $ | +5.193.154 $ | 1 | |
| Vor Biopharma Inc. | VOR | → 0 | Schwach | 16.369.509 $ | -1.469.902 $ | -8,2 % | 1 | 17.839.411 $ | +4.759.843 $ | +36,4 % | 1 | 13.079.568 $ | +13.079.568 $ | 1 | |
| Structure Therapeutics Inc. | GPCR | → 0 | Schwach | 16.771.660 $ | +10.349.540 $ | +161,2 % | 1 | 6.422.120 $ | -146.391 $ | -2,2 % | 1 | 6.568.511 $ | +6.568.511 $ | 1 | |
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Schwach | 14.629.091 $ | +3.664.087 $ | +33,4 % | 1 | 10.965.004 $ | +3.730.599 $ | +51,6 % | 1 | 7.234.405 $ | +7.234.405 $ | 1 | |
| PALVELLA THERAPEUTICS, INC. | PVLA | → 0 | Neutral | 13.739.893 $ | +3.433.083 $ | +33,3 % | 1 | 10.306.810 $ | +1.652.066 $ | +19,1 % | 1 | 8.654.744 $ | +8.654.744 $ | 1 | |
| Zenas BioPharma, Inc. | ZBIO | → 0 | Neutral | 10.830.560 $ | +2.487.871 $ | +29,8 % | 1 | 8.342.689 $ | -3.348.514 $ | -28,6 % | 1 | 11.691.203 $ | +11.691.203 $ | 1 | |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 11.059.461 $ | +404.927 $ | +3,8 % | 1 | 10.654.534 $ | +2.420.921 $ | +29,4 % | 1 | 8.233.613 $ | +8.233.613 $ | 1 | |
| Verastem, Inc. | VSTM | → 0 | Schwach | 4.991.976 $ | -1.934.064 $ | -27,9 % | 1 | 6.926.040 $ | -3.166.548 $ | -31,4 % | 1 | 10.092.588 $ | +10.092.588 $ | 1 | |
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Sehr schwach | 7.647.323 $ | +1.013.070 $ | +15,3 % | 1 | 6.634.253 $ | +1.597.663 $ | +31,7 % | 1 | 5.036.590 $ | +5.036.590 $ | 1 | |
| Inventiva S.A. | IVA | → 0 | Schwach | 6.758.580 $ | -642.256 $ | -8,7 % | 1 | 7.400.836 $ | +1.361.876 $ | +22,6 % | 1 | 6.038.960 $ | +6.038.960 $ | 1 | |
| CRESCENT BIOPHARMA, INC. | CBIO | → 0 | Neutral | 6.711.408 $ | -137.957 $ | -2,0 % | 1 | 6.849.365 $ | +2.427.293 $ | +54,9 % | 1 | 4.422.072 $ | +4.422.072 $ | 1 | |
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 6.232.873 $ | +699.464 $ | +12,6 % | 1 | 5.533.409 $ | +1.127.731 $ | +25,6 % | 1 | 4.405.678 $ | +4.405.678 $ | 1 | |
| Compass Therapeutics, Inc. | CMPX | → 0 | Stark | 4.486.999 $ | -1.495.208 $ | -25,0 % | 1 | 5.982.207 $ | +5.982.207 $ | 1 | |||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 5.072.603 $ | +23.177 $ | +0,5 % | 1 | 5.049.426 $ | +1.645.935 $ | +48,4 % | 1 | 3.403.491 $ | +3.403.491 $ | 1 | |
| Evommune, Inc. | EVMN | → 0 | Neutral | 1.582.347 $ | -2.649.261 $ | -62,6 % | 1 | 4.231.608 $ | +323.352 $ | +8,3 % | 1 | 3.908.256 $ | +3.908.256 $ | 1 | |
| Oculis Holding AG | OCS | → 0 | Sehr stark | 3.977.651 $ | +987.143 $ | +33,0 % | 1 | 2.990.508 $ | +2.990.508 $ | 1 | |||||
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 3.851.187 $ | +484.426 $ | +14,4 % | 1 | 3.366.761 $ | -30.240 $ | -0,9 % | 1 | 3.397.001 $ | +3.397.001 $ | 1 | |
| Pharvaris N.V. | PHVS | → 0 | Stark | 3.736.542 $ | +3.736.542 $ | 1 | |||||||||
| Zai Lab Ltd | ZLAB | → 0 | Sehr schwach | 3.483.878 $ | +34.839 $ | +1,0 % | 1 | 3.449.039 $ | +567.333 $ | +19,7 % | 1 | 2.881.706 $ | +2.881.706 $ | 1 | |
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 2.653.053 $ | +524.548 $ | +24,6 % | 1 | 2.128.505 $ | +2.128.505 $ | 1 | ||||||
| BioAge Labs, Inc. | BIOA | → 0 | Neutral | 2.468.941 $ | +2.468.941 $ | 1 | |||||||||
| LB PHARMACEUTICALS INC | LBRX | → 0 | Schwach | 2.215.021 $ | +2.215.021 $ | 1 | |||||||||
| Summit Therapeutics Inc. | SMMT | → 0 | Neutral | 1.701.034 $ | +1.701.034 $ | 1 | |||||||||
| Adicet Bio, Inc. | ACET | → 0 | Neutral | 1.363.625 $ | +288.823 $ | +26,9 % | 1 | 1.074.802 $ | -254.101 $ | -19,1 % | 1 | 1.328.903 $ | +1.328.903 $ | 1 | |
| 217.397.102 $ | +46.716.869 $ | +20,3 % | 22 | 215.370.002 $ | +44.878.179 $ | +24,1 % | 24 | 170.491.823 $ | +170.491.823 $ | 23 | |||||